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   A 49-year-old male with left renal cell carcinoma and urothelial cancer (bladder and residual 
left ureter), which asynchronously occurred, was reported. He had received radical nephrectomy 
due to renal cell carcinoma 12 years earlier. 
   He was followed up by his local physician for 7 years postoperatively, during which time no 
metastatic lesion was detected. However, he presented with macroscopic hematuria on January 7, 
1992, and a diagnosis of urinary bladder cancer was made at our hospital. 
   Computerized tomography demonstrated a non-papillary, broad-based tumor on the left wall 
of the urinary bladder, which histologically was transitional cell carcinoma (grade 3). Radical 
cystectomy, ureterectomy of the left residual ureter and ileal conduit were performed. Histological 
examinations showed that the urinary bladder tumor was transitional cell carcinoma, grade 3, pT-
3b, and CIS (transitional cell carcinoma, grade 3) was found in the residual left ureter. 
   Chemotherapy containing cis-platinum was performed as an adjuvant therapy, but multiple 
lung metastatic lesions appeared 2 months postoperatively, the histology of which was transitional 
cell carcinoma, suggesting metastasis from the urothelial cancer. Chemotherapy was ineffective, 
and he died of the disease 9 months after the operation. If this patient had been under long-
term follow-up, the urothelial cancer may have been resected completely by transurethral rese 
ction. 
   Our report indicated the importance of examination of the urinary tract in patients with such 
cancers, as well as the necessity of long-term follow-up. 
                                                (Acta Urol. Jpn. 39: 927-930, 1993) 























瘍 との診断を うけ加療 目的にて1992年1月7日当科へ
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CAB療 法3)を施 行 した が,2ヵ 月 目に 肺 に多 数 の結
節 性 陰 影 を 認 めた.転 移 巣 の組 織 学 的 診 断 確 立 のた め
経 皮 的 肺 腫 瘍 生 検 を 施行 した.転 移 巣 の 病 理学 的所 見
は,移 行上 皮 癌,grade3で尿 路 移 行 上 皮 腫 瘍 の 転移
と考 え られ た.さ らにMVP-CAB療 法 を2ク ール追
加 施 行 した が,効 果 を 認 め な か った た め化 学 療 法 レジ
メ ソを 変更 し,5-FUとinterferon一α の併 用 療法4)
を 施 行 した.し か しそ の効 果 な く,膀 胱 全摘 術 後,約




























泌尿器科学的領域 における重複癌 は,膀 胱と前立
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